BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations

Marta Cigognetti(University of Brescia), Silvia Lonardi(University of Brescia), Simona Fisogni(University of Brescia), Piera Balzarini(University of Brescia), Vilma Pellegrini(University of Brescia), Andrea Tironi(University of Brescia), Luisa Bercich(University of Brescia), Mattia Bugatti(University of Brescia), Giulio Rossi(Policlinico di Modena), Bruno Murer(Ospedale dell' Angelo), Mattia Barbareschi, Silvia Giuliani, Alberto Cavazza(Azienda Ospedaliera S.Maria), Gianpietro Marchetti(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), William Vermi(University of Brescia), Fabio Facchetti(University of Brescia)
Modern Pathology
May 29, 2015
10.1038/modpathol.2015.65
Cited by 303Open Access
Full Text

Abstract

Related Papers

WHO classification of tumours of the lung, pleura, thymus and heart
William D. Travis|International Agency for Research on Cancer eBooks|2015|1.7k
The European mesothelioma epidemic
Julian Peto, Adriano Decarli, Carlo La Vecchia et al.|British Journal of Cancer|1999|899
BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression
David E. Jensen, Monja L. Proctor, Sandra T. Marquis et al.|Oncogene|1998|724
BRCA1-Associated Protein-1 Is a Tumor Suppressor that Requires Deubiquitinating Activity and Nuclear Localization
Karen Ventii, Narra S. Devi, Kenneth L. Friedrich et al.|Cancer Research|2008|335
BAP1 Immunohistochemistry and p16 FISH to Separate Benign From Malignant Mesothelial Proliferations
Brandon S. Sheffield, Harry C. Hwang, Anna F. Lee et al.|The American Journal of Surgical Pathology|2015|185